Oral androstenedione administration and serum testosterone concentrations in young men

被引:87
作者
Leder, BZ
Longcope, C
Catlin, DH
Ahrens, B
Schoenfeld, DA
Finkelstein, JS
机构
[1] Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Biostat, Boston, MA 02114 USA
[3] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA
[4] Univ Massachusetts, Sch Med, Dept Obstet & Gynecol, Worcester, MA USA
[5] Univ Calif Los Angeles, Dept Med, Olymp Analyt Lab, Los Angeles, CA USA
[6] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2000年 / 283卷 / 06期
关键词
D O I
10.1001/jama.283.6.779
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Androstenedione, a steroid hormone and the major precursor to testosterone, is available without prescription and is purported to increase strength and athletic performance. The hormonal effects of androstenedione, however, are unknown. Objective To determine if oral administration of androstenedione increases serum testosterone levels in healthy men. Design Open-label randomized controlled trial conducted between October 1998 and April 1999. Setting General clinical research center of a tertiary-care, university-affiliate hospital. Participants Forty-two healthy men aged 20 to 40 years, Intervention Subjects were randomized to receive oral androstenedione (either 100 mg/d [n = 15] or 300 mg/d [n = 14]) or no androstenedione (n = 13) for 7 days. Main Outcome Measures Changes in serum testosterone, androstenedione, estrone, and estradiol levels, measured by frequent blood sampling, compared among the 3 treatment groups. Results Mean (SE) changes in the area under the curve (AUC) for serum testosterone concentrations were -2% (7%), -4% (4%), and 34% (14%) in the groups receiving 0, 100, and 300 mg/d of androstenedione, respectively. When compared with the control group, the change in testosterone AUC was significant for the 300-mg/d group (P<.001) but not for the 100-mg/d group (P = .48). Baseline testosterone levels, drawn 24 hours after androstenedione administration, did not change. Mean (SE) changes in the AUC for serum estradiol concentrations were 4% (6%), 42% (12%), and 128% (24%) in the groups receiving 0, 100, and 300 mg/d of androstenedione, respectively. When compared with the control group, the change in the estradiol AUC was significant for both the 300-mg/d (P<.001) and 100-mg/d (P = .002) groups. There was marked variability in individual responses for all measured sex steroids. Conclusions Our data suggest that oral androstenedione, when given in dosages of 300 mg/d, increases serum testosterone and estradiol concentrations in some healthy men.
引用
收藏
页码:779 / 782
页数:4
相关论文
共 23 条
  • [1] EFFECT OF TESTOSTERONE ENANTHATE ON SERUM-LIPOPROTEINS IN MAN
    ANDERSON, RA
    WALLACE, EM
    WU, FCW
    [J]. CONTRACEPTION, 1995, 52 (02) : 115 - 119
  • [2] PELIOSIS HEPATIS ASSOCIATED WITH ANDROGENIC-ANABOLIC STEROID-THERAPY - SEVERE FORM OF HEPATIC INJURY
    BAGHERI, SA
    BOYER, JL
    [J]. ANNALS OF INTERNAL MEDICINE, 1974, 81 (05) : 610 - 618
  • [3] The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
    Bhasin, S
    Storer, TW
    Berman, N
    Callegari, C
    Clevenger, B
    Phillips, J
    Bunnell, TJ
    Tricker, R
    Shirazi, A
    Casaburi, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (01) : 1 - 7
  • [4] LINEAR GROWTH AS A FUNCTION OF AGE AT ONSET OF PUBERTY AND SEX STEROID DOSAGE - THERAPEUTIC IMPLICATIONS
    BOURGUIGNON, JP
    [J]. ENDOCRINE REVIEWS, 1988, 9 (04) : 467 - 488
  • [5] SUDDEN CARDIAC DEATH IN A 20-YEAR-OLD BODYBUILDER USING ANABOLIC-STEROIDS
    DICKERMAN, RD
    SCHALLER, F
    PRATHER, I
    MCCONATHY, WJ
    [J]. CARDIOLOGY, 1995, 86 (02) : 172 - 173
  • [6] AROMATIZATION OF ANDROSTENEDIONE TO ESTRONE BY HUMAN ADIPOSE-TISSUE INVITRO - CORRELATION WITH ADIPOSE-TISSUE MASS, AGE, AND ENDOMETRIAL NEOPLASIA
    FORNEY, JP
    MILEWICH, L
    CHEN, GT
    GARLOCK, JL
    SCHWARZ, BE
    EDMAN, CD
    MACDONALD, PC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (01) : 192 - 199
  • [7] ANDROSTENEDIONE PRODUCTION AND INTERCONVERSION RATES MEASURED IN PERIPHERAL BLOOD AND STUDIES ON POSSIBLE SITE OF ITS CONVERSION TO TESTOSTERONE
    HORTON, R
    TAIT, JF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1966, 45 (03) : 301 - &
  • [8] HEPATOTOXIC EFFECTS OF THE ANABOLIC ANDROGENIC STEROIDS
    ISHAK, KG
    ZIMMERMAN, HJ
    [J]. SEMINARS IN LIVER DISEASE, 1987, 7 (03) : 230 - 236
  • [9] Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men - A randomized controlled trial
    King, DS
    Sharp, RL
    Vukovich, MD
    Brown, GA
    Reifenrath, TA
    Uhl, NL
    Parsons, KA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (21): : 2020 - 2028
  • [10] STRUCTURE, REGULATION AND ROLE OF 3-BETA-HYDROXYSTEROID DEHYDROGENASE, 17-BETA-HYDROXYSTEROID DEHYDROGENASE AND AROMATASE ENZYMES IN THE FORMATION OF SEX STEROIDS IN CLASSICAL AND PERIPHERAL INTRACRINE TISSUES
    LABRIE, F
    SIMARD, J
    LUUTHE, V
    PELLETIER, G
    BELGHMI, K
    BELANGER, A
    [J]. BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1994, 8 (02): : 451 - 474